top of page

Explore the Trial

What is the trial about? 

The purpose of this study is to find the most effective dose of radiation therapy to give to breast tumors in a shorter period of time, prior to standard partial mastectomy/axillary surgery.


How long is the trial?

The trial should take around 3 years and has a start date of August 5, 2020.


What is the phase of trial?

This is a Phase I trial.


How is the trial randomized?

The trial is randomized by...


What are the arms of the trial?

Some patients will undergo the experimental side which included Preoperative Stereotactic Ablative Breast Radiotherapy (SABER). The study has testing up to 4 dose levels. Other patients will experience the standard non-experimental procedure. This means they will undergo standard partial mastectomy and axillary surgery as per discretion of treating physician.


Is there any data from the trial?

The SABER procedure has shown to have great success in other studies. The data indicates...


How many patients are enrolled in the trial?

There will be a total of 15 patients enrolled in this trial.


Who is sponsoring the trial?

University of Miami is sponsoring this trial.

Get in Touch

Contact your oncologist @ (123)-456-7890 or visit your clinical trial

bottom of page